NASDAQ
Eagle Pharmaceuticals, Inc. (EGRX) has a fcf yield of 0.00% as of Friday, May 29, 2026. This represents a 100.00% decrease compared to its 12-month average of 8.00%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.